nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ADRB2—ulcerative colitis	0.395	0.687	CbGaD
Acebutolol—ABCB1—ulcerative colitis	0.18	0.313	CbGaD
Acebutolol—SLC22A1—Nicotine—ulcerative colitis	0.0944	0.347	CbGbCtD
Acebutolol—ABCB1—Methylprednisolone—ulcerative colitis	0.0297	0.109	CbGbCtD
Acebutolol—CYP2D6—Nicotine—ulcerative colitis	0.0273	0.1	CbGbCtD
Acebutolol—CYP2D6—Cholecalciferol—ulcerative colitis	0.0245	0.0899	CbGbCtD
Acebutolol—ABCB1—Betamethasone—ulcerative colitis	0.0193	0.071	CbGbCtD
Acebutolol—ABCB1—Prednisolone—ulcerative colitis	0.019	0.07	CbGbCtD
Acebutolol—ABCB1—Hydrocortisone—ulcerative colitis	0.0181	0.0664	CbGbCtD
Acebutolol—ABCB1—Prednisone—ulcerative colitis	0.018	0.0661	CbGbCtD
Acebutolol—ABCB1—Dexamethasone—ulcerative colitis	0.0112	0.0413	CbGbCtD
Acebutolol—CYP2D6—Dexamethasone—ulcerative colitis	0.0106	0.0389	CbGbCtD
Acebutolol—SLC22A1—Organic cation transport—SLC22A4—ulcerative colitis	0.00189	0.0963	CbGpPWpGaD
Acebutolol—SLC22A1—Organic cation transport—SLC22A5—ulcerative colitis	0.00189	0.0963	CbGpPWpGaD
Acebutolol—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.00128	0.0653	CbGpPWpGaD
Acebutolol—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.00128	0.0653	CbGpPWpGaD
Acebutolol—SLC22A1—Abacavir transmembrane transport—ABCB1—ulcerative colitis	0.000986	0.0503	CbGpPWpGaD
Acebutolol—ADRB1—Adrenoceptors—ADRB2—ulcerative colitis	0.000763	0.0389	CbGpPWpGaD
Acebutolol—Metipranolol—ADRB2—ulcerative colitis	0.000762	0.141	CrCbGaD
Acebutolol—Esmolol—ADRB2—ulcerative colitis	0.000605	0.112	CrCbGaD
Acebutolol—SLC22A1—Abacavir transport and metabolism—ABCB1—ulcerative colitis	0.000566	0.0289	CbGpPWpGaD
Acebutolol—Betaxolol—ADRB2—ulcerative colitis	0.000533	0.0988	CrCbGaD
Acebutolol—Atenolol—ADRB2—ulcerative colitis	0.000528	0.0979	CrCbGaD
Acebutolol—Bisoprolol—ADRB2—ulcerative colitis	0.000514	0.0954	CrCbGaD
Acebutolol—Oxprenolol—ADRB2—ulcerative colitis	0.000484	0.0897	CrCbGaD
Acebutolol—Alprenolol—ADRB2—ulcerative colitis	0.000442	0.0821	CrCbGaD
Acebutolol—Metoprolol—ADRB2—ulcerative colitis	0.000411	0.0763	CrCbGaD
Acebutolol—Pindolol—ADRB2—ulcerative colitis	0.00038	0.0706	CrCbGaD
Acebutolol—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000374	0.0191	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000337	0.0172	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000296	0.0151	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00029	0.0148	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—ADRB2—ulcerative colitis	0.00027	0.0138	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000257	0.0131	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000257	0.0131	CbGpPWpGaD
Acebutolol—Atenolol—ABCB1—ulcerative colitis	0.000241	0.0446	CrCbGaD
Acebutolol—ADRB2—GPCRs, Other—CXCR1—ulcerative colitis	0.000239	0.0122	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.000227	0.0116	CbGpPWpGaD
Acebutolol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000217	0.011	CbGpPWpGaD
Acebutolol—Propranolol—ADRB2—ulcerative colitis	0.000208	0.0385	CrCbGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000198	0.0101	CbGpPWpGaD
Acebutolol—Metoprolol—ABCB1—ulcerative colitis	0.000187	0.0348	CrCbGaD
Acebutolol—ADRB2—GPCRs, Other—CXCR2—ulcerative colitis	0.000187	0.00953	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.00016	0.00815	CbGpPWpGaD
Acebutolol—Angiopathy—Betamethasone—ulcerative colitis	0.000141	0.00111	CcSEcCtD
Acebutolol—Rash—Budesonide—ulcerative colitis	0.000141	0.0011	CcSEcCtD
Acebutolol—Dermatitis—Budesonide—ulcerative colitis	0.000141	0.0011	CcSEcCtD
Acebutolol—Headache—Budesonide—ulcerative colitis	0.00014	0.0011	CcSEcCtD
Acebutolol—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000139	0.00109	CcSEcCtD
Acebutolol—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000138	0.00108	CcSEcCtD
Acebutolol—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000138	0.00108	CcSEcCtD
Acebutolol—Bradycardia—Prednisone—ulcerative colitis	0.000138	0.00108	CcSEcCtD
Acebutolol—Alopecia—Dexamethasone—ulcerative colitis	0.000137	0.00108	CcSEcCtD
Acebutolol—Alopecia—Betamethasone—ulcerative colitis	0.000137	0.00108	CcSEcCtD
Acebutolol—Diarrhoea—Azathioprine—ulcerative colitis	0.000136	0.00107	CcSEcCtD
Acebutolol—Discomfort—Prednisolone—ulcerative colitis	0.000136	0.00107	CcSEcCtD
Acebutolol—Myalgia—Hydrocortisone—ulcerative colitis	0.000135	0.00106	CcSEcCtD
Acebutolol—Hallucination—Prednisone—ulcerative colitis	0.000134	0.00106	CcSEcCtD
Acebutolol—Malaise—Triamcinolone—ulcerative colitis	0.000134	0.00105	CcSEcCtD
Acebutolol—Anxiety—Hydrocortisone—ulcerative colitis	0.000134	0.00105	CcSEcCtD
Acebutolol—Malaise—Methylprednisolone—ulcerative colitis	0.000134	0.00105	CcSEcCtD
Acebutolol—Vertigo—Triamcinolone—ulcerative colitis	0.000134	0.00105	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000134	0.00105	CcSEcCtD
Acebutolol—Syncope—Triamcinolone—ulcerative colitis	0.000133	0.00105	CcSEcCtD
Acebutolol—Vertigo—Methylprednisolone—ulcerative colitis	0.000133	0.00105	CcSEcCtD
Acebutolol—Syncope—Methylprednisolone—ulcerative colitis	0.000133	0.00105	CcSEcCtD
Acebutolol—Discomfort—Hydrocortisone—ulcerative colitis	0.000133	0.00104	CcSEcCtD
Acebutolol—Connective tissue disorder—Prednisone—ulcerative colitis	0.000133	0.00104	CcSEcCtD
Acebutolol—Nausea—Budesonide—ulcerative colitis	0.000133	0.00104	CcSEcCtD
Acebutolol—Oedema—Prednisolone—ulcerative colitis	0.000132	0.00104	CcSEcCtD
Acebutolol—Dizziness—Azathioprine—ulcerative colitis	0.000132	0.00103	CcSEcCtD
Acebutolol—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000131	0.00103	CcSEcCtD
Acebutolol—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000131	0.00103	CcSEcCtD
Acebutolol—Asthenia—Mesalazine—ulcerative colitis	0.00013	0.00102	CcSEcCtD
Acebutolol—Shock—Prednisolone—ulcerative colitis	0.00013	0.00102	CcSEcCtD
Acebutolol—Cough—Triamcinolone—ulcerative colitis	0.00013	0.00102	CcSEcCtD
Acebutolol—ADRB1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000129	0.0066	CbGpPWpGaD
Acebutolol—Oedema—Hydrocortisone—ulcerative colitis	0.000129	0.00101	CcSEcCtD
Acebutolol—Pruritus—Mesalazine—ulcerative colitis	0.000128	0.00101	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000128	0.001	CcSEcCtD
Acebutolol—Shock—Hydrocortisone—ulcerative colitis	0.000127	0.000997	CcSEcCtD
Acebutolol—Myalgia—Triamcinolone—ulcerative colitis	0.000127	0.000995	CcSEcCtD
Acebutolol—Vomiting—Azathioprine—ulcerative colitis	0.000127	0.000994	CcSEcCtD
Acebutolol—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000127	0.000994	CcSEcCtD
Acebutolol—Myalgia—Methylprednisolone—ulcerative colitis	0.000126	0.000993	CcSEcCtD
Acebutolol—Arthralgia—Methylprednisolone—ulcerative colitis	0.000126	0.000993	CcSEcCtD
Acebutolol—Anxiety—Methylprednisolone—ulcerative colitis	0.000126	0.000989	CcSEcCtD
Acebutolol—Rash—Azathioprine—ulcerative colitis	0.000126	0.000986	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000126	0.000986	CcSEcCtD
Acebutolol—Dermatitis—Azathioprine—ulcerative colitis	0.000125	0.000985	CcSEcCtD
Acebutolol—Flushing—Prednisone—ulcerative colitis	0.000125	0.000985	CcSEcCtD
Acebutolol—Skin disorder—Hydrocortisone—ulcerative colitis	0.000125	0.000984	CcSEcCtD
Acebutolol—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000125	0.000984	CcSEcCtD
Acebutolol—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000125	0.000984	CcSEcCtD
Acebutolol—Discomfort—Triamcinolone—ulcerative colitis	0.000125	0.000983	CcSEcCtD
Acebutolol—Discomfort—Methylprednisolone—ulcerative colitis	0.000125	0.000981	CcSEcCtD
Acebutolol—Headache—Azathioprine—ulcerative colitis	0.000125	0.00098	CcSEcCtD
Acebutolol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000125	0.000979	CcSEcCtD
Acebutolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000124	0.00634	CbGpPWpGaD
Acebutolol—Diarrhoea—Mesalazine—ulcerative colitis	0.000124	0.000975	CcSEcCtD
Acebutolol—ADRB1—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000124	0.0063	CbGpPWpGaD
Acebutolol—Anorexia—Hydrocortisone—ulcerative colitis	0.000123	0.000966	CcSEcCtD
Acebutolol—Angiopathy—Prednisone—ulcerative colitis	0.000123	0.000963	CcSEcCtD
Acebutolol—Confusional state—Methylprednisolone—ulcerative colitis	0.000122	0.00096	CcSEcCtD
Acebutolol—Malaise—Dexamethasone—ulcerative colitis	0.000122	0.000956	CcSEcCtD
Acebutolol—Malaise—Betamethasone—ulcerative colitis	0.000122	0.000956	CcSEcCtD
Acebutolol—Oedema—Triamcinolone—ulcerative colitis	0.000121	0.000954	CcSEcCtD
Acebutolol—Vertigo—Betamethasone—ulcerative colitis	0.000121	0.000953	CcSEcCtD
Acebutolol—Vertigo—Dexamethasone—ulcerative colitis	0.000121	0.000953	CcSEcCtD
Acebutolol—Syncope—Betamethasone—ulcerative colitis	0.000121	0.000951	CcSEcCtD
Acebutolol—Syncope—Dexamethasone—ulcerative colitis	0.000121	0.000951	CcSEcCtD
Acebutolol—ADRB2—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000121	0.00616	CbGpPWpGaD
Acebutolol—Hypotension—Hydrocortisone—ulcerative colitis	0.000121	0.000947	CcSEcCtD
Acebutolol—ADRB2—Arf6 trafficking events—CDH1—ulcerative colitis	0.00012	0.00612	CbGpPWpGaD
Acebutolol—Dizziness—Mesalazine—ulcerative colitis	0.00012	0.000942	CcSEcCtD
Acebutolol—Shock—Triamcinolone—ulcerative colitis	0.00012	0.000939	CcSEcCtD
Acebutolol—Insomnia—Prednisolone—ulcerative colitis	0.000119	0.000938	CcSEcCtD
Acebutolol—Alopecia—Prednisone—ulcerative colitis	0.000119	0.000938	CcSEcCtD
Acebutolol—Shock—Methylprednisolone—ulcerative colitis	0.000119	0.000936	CcSEcCtD
Acebutolol—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000119	0.000933	CcSEcCtD
Acebutolol—Loss of consciousness—Betamethasone—ulcerative colitis	0.000119	0.000932	CcSEcCtD
Acebutolol—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000119	0.000932	CcSEcCtD
Acebutolol—Paraesthesia—Prednisolone—ulcerative colitis	0.000119	0.000931	CcSEcCtD
Acebutolol—Nausea—Azathioprine—ulcerative colitis	0.000118	0.000929	CcSEcCtD
Acebutolol—Skin disorder—Methylprednisolone—ulcerative colitis	0.000118	0.000925	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000118	0.000923	CcSEcCtD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000118	0.00599	CbGpPWpGaD
Acebutolol—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000117	0.000922	CcSEcCtD
Acebutolol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000117	0.00092	CcSEcCtD
Acebutolol—Insomnia—Hydrocortisone—ulcerative colitis	0.000117	0.000916	CcSEcCtD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000117	0.00594	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000117	0.00594	CbGpPWpGaD
Acebutolol—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000116	0.00091	CcSEcCtD
Acebutolol—Vomiting—Mesalazine—ulcerative colitis	0.000115	0.000906	CcSEcCtD
Acebutolol—Myalgia—Dexamethasone—ulcerative colitis	0.000115	0.000903	CcSEcCtD
Acebutolol—Myalgia—Betamethasone—ulcerative colitis	0.000115	0.000903	CcSEcCtD
Acebutolol—Anxiety—Betamethasone—ulcerative colitis	0.000115	0.0009	CcSEcCtD
Acebutolol—Anxiety—Dexamethasone—ulcerative colitis	0.000115	0.0009	CcSEcCtD
Acebutolol—Rash—Mesalazine—ulcerative colitis	0.000114	0.000898	CcSEcCtD
Acebutolol—Dermatitis—Mesalazine—ulcerative colitis	0.000114	0.000897	CcSEcCtD
Acebutolol—Headache—Mesalazine—ulcerative colitis	0.000114	0.000893	CcSEcCtD
Acebutolol—Discomfort—Betamethasone—ulcerative colitis	0.000114	0.000892	CcSEcCtD
Acebutolol—Discomfort—Dexamethasone—ulcerative colitis	0.000114	0.000892	CcSEcCtD
Acebutolol—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000114	0.000892	CcSEcCtD
Acebutolol—Hypotension—Methylprednisolone—ulcerative colitis	0.000113	0.000889	CcSEcCtD
Acebutolol—Pain—Prednisolone—ulcerative colitis	0.000113	0.000887	CcSEcCtD
Acebutolol—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000112	0.000881	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000111	0.000875	CcSEcCtD
Acebutolol—Fatigue—Hydrocortisone—ulcerative colitis	0.000111	0.000873	CcSEcCtD
Acebutolol—Vision blurred—Prednisone—ulcerative colitis	0.000111	0.00087	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000111	0.000869	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00011	0.000867	CcSEcCtD
Acebutolol—Pain—Hydrocortisone—ulcerative colitis	0.00011	0.000866	CcSEcCtD
Acebutolol—Oedema—Dexamethasone—ulcerative colitis	0.00011	0.000866	CcSEcCtD
Acebutolol—Oedema—Betamethasone—ulcerative colitis	0.00011	0.000866	CcSEcCtD
Acebutolol—Insomnia—Triamcinolone—ulcerative colitis	0.00011	0.000863	CcSEcCtD
Acebutolol—Insomnia—Methylprednisolone—ulcerative colitis	0.00011	0.000861	CcSEcCtD
Acebutolol—Ill-defined disorder—Prednisone—ulcerative colitis	0.000109	0.000857	CcSEcCtD
Acebutolol—Paraesthesia—Triamcinolone—ulcerative colitis	0.000109	0.000857	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisolone—ulcerative colitis	0.000109	0.000855	CcSEcCtD
Acebutolol—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000109	0.000855	CcSEcCtD
Acebutolol—Shock—Betamethasone—ulcerative colitis	0.000108	0.000852	CcSEcCtD
Acebutolol—Shock—Dexamethasone—ulcerative colitis	0.000108	0.000852	CcSEcCtD
Acebutolol—Dyspnoea—Triamcinolone—ulcerative colitis	0.000108	0.00085	CcSEcCtD
Acebutolol—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000108	0.000849	CcSEcCtD
Acebutolol—Nervous system disorder—Betamethasone—ulcerative colitis	0.000108	0.000849	CcSEcCtD
Acebutolol—Nausea—Mesalazine—ulcerative colitis	0.000108	0.000846	CcSEcCtD
Acebutolol—Dyspepsia—Triamcinolone—ulcerative colitis	0.000107	0.00084	CcSEcCtD
Acebutolol—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000107	0.000838	CcSEcCtD
Acebutolol—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000107	0.000837	CcSEcCtD
Acebutolol—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000107	0.000837	CcSEcCtD
Acebutolol—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000106	0.000835	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000106	0.00541	CbGpPWpGaD
Acebutolol—Malaise—Prednisone—ulcerative colitis	0.000106	0.000833	CcSEcCtD
Acebutolol—Vertigo—Prednisone—ulcerative colitis	0.000106	0.00083	CcSEcCtD
Acebutolol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000105	0.000828	CcSEcCtD
Acebutolol—Syncope—Prednisone—ulcerative colitis	0.000105	0.000828	CcSEcCtD
Acebutolol—Anorexia—Dexamethasone—ulcerative colitis	0.000105	0.000825	CcSEcCtD
Acebutolol—Anorexia—Betamethasone—ulcerative colitis	0.000105	0.000825	CcSEcCtD
Acebutolol—Urticaria—Prednisolone—ulcerative colitis	0.000105	0.000824	CcSEcCtD
Acebutolol—Fatigue—Triamcinolone—ulcerative colitis	0.000105	0.000822	CcSEcCtD
Acebutolol—Fatigue—Methylprednisolone—ulcerative colitis	0.000105	0.000821	CcSEcCtD
Acebutolol—Pain—Triamcinolone—ulcerative colitis	0.000104	0.000816	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000104	0.00529	CbGpPWpGaD
Acebutolol—Loss of consciousness—Prednisone—ulcerative colitis	0.000103	0.000812	CcSEcCtD
Acebutolol—Hypotension—Dexamethasone—ulcerative colitis	0.000103	0.000809	CcSEcCtD
Acebutolol—Hypotension—Betamethasone—ulcerative colitis	0.000103	0.000809	CcSEcCtD
Acebutolol—Urticaria—Hydrocortisone—ulcerative colitis	0.000102	0.000805	CcSEcCtD
Acebutolol—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000102	0.000801	CcSEcCtD
Acebutolol—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000102	0.000801	CcSEcCtD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000101	0.00512	CbGpPWpGaD
Acebutolol—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.0001	0.000789	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.0001	0.000789	CcSEcCtD
Acebutolol—Arthralgia—Prednisone—ulcerative colitis	0.0001	0.000786	CcSEcCtD
Acebutolol—Myalgia—Prednisone—ulcerative colitis	0.0001	0.000786	CcSEcCtD
Acebutolol—Feeling abnormal—Triamcinolone—ulcerative colitis	0.0001	0.000786	CcSEcCtD
Acebutolol—Feeling abnormal—Methylprednisolone—ulcerative colitis	9.99e-05	0.000784	CcSEcCtD
Acebutolol—Anxiety—Prednisone—ulcerative colitis	9.98e-05	0.000784	CcSEcCtD
Acebutolol—Insomnia—Betamethasone—ulcerative colitis	9.97e-05	0.000783	CcSEcCtD
Acebutolol—Insomnia—Dexamethasone—ulcerative colitis	9.97e-05	0.000783	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	9.94e-05	0.000781	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	9.91e-05	0.000778	CcSEcCtD
Acebutolol—Paraesthesia—Betamethasone—ulcerative colitis	9.9e-05	0.000777	CcSEcCtD
Acebutolol—Paraesthesia—Dexamethasone—ulcerative colitis	9.9e-05	0.000777	CcSEcCtD
Acebutolol—Discomfort—Prednisone—ulcerative colitis	9.89e-05	0.000777	CcSEcCtD
Acebutolol—Dyspepsia—Betamethasone—ulcerative colitis	9.7e-05	0.000762	CcSEcCtD
Acebutolol—Dyspepsia—Dexamethasone—ulcerative colitis	9.7e-05	0.000762	CcSEcCtD
Acebutolol—Urticaria—Triamcinolone—ulcerative colitis	9.65e-05	0.000758	CcSEcCtD
Acebutolol—Urticaria—Methylprednisolone—ulcerative colitis	9.63e-05	0.000756	CcSEcCtD
Acebutolol—Body temperature increased—Triamcinolone—ulcerative colitis	9.6e-05	0.000754	CcSEcCtD
Acebutolol—Oedema—Prednisone—ulcerative colitis	9.6e-05	0.000754	CcSEcCtD
Acebutolol—Abdominal pain—Methylprednisolone—ulcerative colitis	9.58e-05	0.000752	CcSEcCtD
Acebutolol—Decreased appetite—Dexamethasone—ulcerative colitis	9.58e-05	0.000752	CcSEcCtD
Acebutolol—Decreased appetite—Betamethasone—ulcerative colitis	9.58e-05	0.000752	CcSEcCtD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	9.56e-05	0.00487	CbGpPWpGaD
Acebutolol—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.52e-05	0.000747	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.52e-05	0.000747	CcSEcCtD
Acebutolol—Fatigue—Dexamethasone—ulcerative colitis	9.5e-05	0.000746	CcSEcCtD
Acebutolol—Fatigue—Betamethasone—ulcerative colitis	9.5e-05	0.000746	CcSEcCtD
Acebutolol—Propranolol—ABCB1—ulcerative colitis	9.46e-05	0.0176	CrCbGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	9.46e-05	0.00482	CbGpPWpGaD
Acebutolol—Shock—Prednisone—ulcerative colitis	9.44e-05	0.000742	CcSEcCtD
Acebutolol—Pain—Betamethasone—ulcerative colitis	9.43e-05	0.00074	CcSEcCtD
Acebutolol—Pain—Dexamethasone—ulcerative colitis	9.43e-05	0.00074	CcSEcCtD
Acebutolol—Nervous system disorder—Prednisone—ulcerative colitis	9.41e-05	0.000739	CcSEcCtD
Acebutolol—ADRB1—G alpha (s) signalling events—ADRB2—ulcerative colitis	9.36e-05	0.00477	CbGpPWpGaD
Acebutolol—Skin disorder—Prednisone—ulcerative colitis	9.32e-05	0.000732	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisone—ulcerative colitis	9.28e-05	0.000729	CcSEcCtD
Acebutolol—Asthenia—Hydrocortisone—ulcerative colitis	9.26e-05	0.000727	CcSEcCtD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	9.25e-05	0.00472	CbGpPWpGaD
Acebutolol—Anorexia—Prednisone—ulcerative colitis	9.15e-05	0.000719	CcSEcCtD
Acebutolol—Pruritus—Hydrocortisone—ulcerative colitis	9.13e-05	0.000717	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	9.09e-05	0.00464	CbGpPWpGaD
Acebutolol—Feeling abnormal—Betamethasone—ulcerative colitis	9.08e-05	0.000713	CcSEcCtD
Acebutolol—Feeling abnormal—Dexamethasone—ulcerative colitis	9.08e-05	0.000713	CcSEcCtD
Acebutolol—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	9.07e-05	0.00462	CbGpPWpGaD
Acebutolol—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.01e-05	0.000708	CcSEcCtD
Acebutolol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.01e-05	0.000708	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	8.89e-05	0.00453	CbGpPWpGaD
Acebutolol—Diarrhoea—Hydrocortisone—ulcerative colitis	8.83e-05	0.000693	CcSEcCtD
Acebutolol—Urticaria—Betamethasone—ulcerative colitis	8.76e-05	0.000688	CcSEcCtD
Acebutolol—Urticaria—Dexamethasone—ulcerative colitis	8.76e-05	0.000688	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Prednisone—ulcerative colitis	8.75e-05	0.000687	CcSEcCtD
Acebutolol—Dizziness—Prednisolone—ulcerative colitis	8.74e-05	0.000686	CcSEcCtD
Acebutolol—Asthenia—Triamcinolone—ulcerative colitis	8.72e-05	0.000684	CcSEcCtD
Acebutolol—Abdominal pain—Betamethasone—ulcerative colitis	8.71e-05	0.000684	CcSEcCtD
Acebutolol—Abdominal pain—Dexamethasone—ulcerative colitis	8.71e-05	0.000684	CcSEcCtD
Acebutolol—Body temperature increased—Dexamethasone—ulcerative colitis	8.71e-05	0.000684	CcSEcCtD
Acebutolol—Body temperature increased—Betamethasone—ulcerative colitis	8.71e-05	0.000684	CcSEcCtD
Acebutolol—Asthenia—Methylprednisolone—ulcerative colitis	8.7e-05	0.000683	CcSEcCtD
Acebutolol—Insomnia—Prednisone—ulcerative colitis	8.68e-05	0.000682	CcSEcCtD
Acebutolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	8.67e-05	0.00442	CbGpPWpGaD
Acebutolol—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.64e-05	0.0044	CbGpPWpGaD
Acebutolol—Paraesthesia—Prednisone—ulcerative colitis	8.62e-05	0.000677	CcSEcCtD
Acebutolol—Pruritus—Triamcinolone—ulcerative colitis	8.59e-05	0.000675	CcSEcCtD
Acebutolol—Pruritus—Methylprednisolone—ulcerative colitis	8.58e-05	0.000673	CcSEcCtD
Acebutolol—Dizziness—Hydrocortisone—ulcerative colitis	8.53e-05	0.00067	CcSEcCtD
Acebutolol—Dyspepsia—Prednisone—ulcerative colitis	8.45e-05	0.000664	CcSEcCtD
Acebutolol—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	8.43e-05	0.0043	CbGpPWpGaD
Acebutolol—Decreased appetite—Prednisone—ulcerative colitis	8.34e-05	0.000655	CcSEcCtD
Acebutolol—Rash—Prednisolone—ulcerative colitis	8.33e-05	0.000654	CcSEcCtD
Acebutolol—Dermatitis—Prednisolone—ulcerative colitis	8.32e-05	0.000653	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	8.3e-05	0.00423	CbGpPWpGaD
Acebutolol—Diarrhoea—Methylprednisolone—ulcerative colitis	8.29e-05	0.000651	CcSEcCtD
Acebutolol—Fatigue—Prednisone—ulcerative colitis	8.28e-05	0.00065	CcSEcCtD
Acebutolol—Headache—Prednisolone—ulcerative colitis	8.28e-05	0.00065	CcSEcCtD
Acebutolol—Constipation—Prednisone—ulcerative colitis	8.21e-05	0.000645	CcSEcCtD
Acebutolol—Vomiting—Hydrocortisone—ulcerative colitis	8.2e-05	0.000644	CcSEcCtD
Acebutolol—Rash—Hydrocortisone—ulcerative colitis	8.13e-05	0.000639	CcSEcCtD
Acebutolol—Dermatitis—Hydrocortisone—ulcerative colitis	8.13e-05	0.000638	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	8.12e-05	0.00414	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	8.08e-05	0.00412	CbGpPWpGaD
Acebutolol—Headache—Hydrocortisone—ulcerative colitis	8.08e-05	0.000635	CcSEcCtD
Acebutolol—Dizziness—Triamcinolone—ulcerative colitis	8.03e-05	0.000631	CcSEcCtD
Acebutolol—Dizziness—Methylprednisolone—ulcerative colitis	8.02e-05	0.000629	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	7.98e-05	0.00407	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—ADCY5—ulcerative colitis	7.95e-05	0.00405	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	7.93e-05	0.00404	CbGpPWpGaD
Acebutolol—Feeling abnormal—Prednisone—ulcerative colitis	7.91e-05	0.000621	CcSEcCtD
Acebutolol—Asthenia—Dexamethasone—ulcerative colitis	7.91e-05	0.000621	CcSEcCtD
Acebutolol—Asthenia—Betamethasone—ulcerative colitis	7.91e-05	0.000621	CcSEcCtD
Acebutolol—Gastrointestinal pain—Prednisone—ulcerative colitis	7.85e-05	0.000616	CcSEcCtD
Acebutolol—Nausea—Prednisolone—ulcerative colitis	7.85e-05	0.000616	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	7.81e-05	0.00398	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	7.81e-05	0.00398	CbGpPWpGaD
Acebutolol—Pruritus—Betamethasone—ulcerative colitis	7.8e-05	0.000612	CcSEcCtD
Acebutolol—Pruritus—Dexamethasone—ulcerative colitis	7.8e-05	0.000612	CcSEcCtD
Acebutolol—ADRB2—G alpha (s) signalling events—ADCY5—ulcerative colitis	7.77e-05	0.00396	CbGpPWpGaD
Acebutolol—Vomiting—Triamcinolone—ulcerative colitis	7.72e-05	0.000607	CcSEcCtD
Acebutolol—Vomiting—Methylprednisolone—ulcerative colitis	7.71e-05	0.000605	CcSEcCtD
Acebutolol—Nausea—Hydrocortisone—ulcerative colitis	7.66e-05	0.000602	CcSEcCtD
Acebutolol—Rash—Triamcinolone—ulcerative colitis	7.66e-05	0.000601	CcSEcCtD
Acebutolol—Dermatitis—Triamcinolone—ulcerative colitis	7.65e-05	0.000601	CcSEcCtD
Acebutolol—Rash—Methylprednisolone—ulcerative colitis	7.64e-05	0.0006	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	7.64e-05	0.00389	CbGpPWpGaD
Acebutolol—Dermatitis—Methylprednisolone—ulcerative colitis	7.64e-05	0.0006	CcSEcCtD
Acebutolol—Urticaria—Prednisone—ulcerative colitis	7.63e-05	0.000599	CcSEcCtD
Acebutolol—Headache—Triamcinolone—ulcerative colitis	7.61e-05	0.000598	CcSEcCtD
Acebutolol—Headache—Methylprednisolone—ulcerative colitis	7.59e-05	0.000596	CcSEcCtD
Acebutolol—Abdominal pain—Prednisone—ulcerative colitis	7.59e-05	0.000596	CcSEcCtD
Acebutolol—Body temperature increased—Prednisone—ulcerative colitis	7.59e-05	0.000596	CcSEcCtD
Acebutolol—Diarrhoea—Dexamethasone—ulcerative colitis	7.54e-05	0.000592	CcSEcCtD
Acebutolol—Diarrhoea—Betamethasone—ulcerative colitis	7.54e-05	0.000592	CcSEcCtD
Acebutolol—Dizziness—Betamethasone—ulcerative colitis	7.29e-05	0.000572	CcSEcCtD
Acebutolol—Dizziness—Dexamethasone—ulcerative colitis	7.29e-05	0.000572	CcSEcCtD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	7.26e-05	0.0037	CbGpPWpGaD
Acebutolol—Nausea—Triamcinolone—ulcerative colitis	7.22e-05	0.000567	CcSEcCtD
Acebutolol—Nausea—Methylprednisolone—ulcerative colitis	7.2e-05	0.000565	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	7.11e-05	0.00363	CbGpPWpGaD
Acebutolol—Vomiting—Betamethasone—ulcerative colitis	7.01e-05	0.00055	CcSEcCtD
Acebutolol—Vomiting—Dexamethasone—ulcerative colitis	7.01e-05	0.00055	CcSEcCtD
Acebutolol—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	6.98e-05	0.00356	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	6.96e-05	0.00355	CbGpPWpGaD
Acebutolol—Rash—Dexamethasone—ulcerative colitis	6.95e-05	0.000546	CcSEcCtD
Acebutolol—Rash—Betamethasone—ulcerative colitis	6.95e-05	0.000546	CcSEcCtD
Acebutolol—Dermatitis—Betamethasone—ulcerative colitis	6.94e-05	0.000545	CcSEcCtD
Acebutolol—Dermatitis—Dexamethasone—ulcerative colitis	6.94e-05	0.000545	CcSEcCtD
Acebutolol—ADRB1—GPCR ligand binding—CXCR1—ulcerative colitis	6.92e-05	0.00353	CbGpPWpGaD
Acebutolol—Headache—Betamethasone—ulcerative colitis	6.91e-05	0.000542	CcSEcCtD
Acebutolol—Headache—Dexamethasone—ulcerative colitis	6.91e-05	0.000542	CcSEcCtD
Acebutolol—Asthenia—Prednisone—ulcerative colitis	6.89e-05	0.000541	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	6.87e-05	0.0035	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	6.86e-05	0.0035	CbGpPWpGaD
Acebutolol—Pruritus—Prednisone—ulcerative colitis	6.79e-05	0.000533	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—CXCR1—ulcerative colitis	6.77e-05	0.00345	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	6.72e-05	0.00343	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	6.71e-05	0.00342	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	6.69e-05	0.00341	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CALM3—ulcerative colitis	6.63e-05	0.00338	CbGpPWpGaD
Acebutolol—Diarrhoea—Prednisone—ulcerative colitis	6.57e-05	0.000516	CcSEcCtD
Acebutolol—Nausea—Betamethasone—ulcerative colitis	6.55e-05	0.000514	CcSEcCtD
Acebutolol—Nausea—Dexamethasone—ulcerative colitis	6.55e-05	0.000514	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	6.54e-05	0.00334	CbGpPWpGaD
Acebutolol—Dizziness—Prednisone—ulcerative colitis	6.35e-05	0.000498	CcSEcCtD
Acebutolol—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	6.34e-05	0.00323	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL10—ulcerative colitis	6.17e-05	0.00314	CbGpPWpGaD
Acebutolol—Vomiting—Prednisone—ulcerative colitis	6.1e-05	0.000479	CcSEcCtD
Acebutolol—ADRB1—GPCR ligand binding—CCL20—ulcerative colitis	6.08e-05	0.0031	CbGpPWpGaD
Acebutolol—Rash—Prednisone—ulcerative colitis	6.05e-05	0.000475	CcSEcCtD
Acebutolol—Dermatitis—Prednisone—ulcerative colitis	6.05e-05	0.000475	CcSEcCtD
Acebutolol—Headache—Prednisone—ulcerative colitis	6.01e-05	0.000472	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—CCL20—ulcerative colitis	5.95e-05	0.00303	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.92e-05	0.00302	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.92e-05	0.00302	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5.89e-05	0.003	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.89e-05	0.003	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.76e-05	0.00294	CbGpPWpGaD
Acebutolol—Nausea—Prednisone—ulcerative colitis	5.7e-05	0.000448	CcSEcCtD
Acebutolol—ADRB1—GPCR ligand binding—CXCR2—ulcerative colitis	5.42e-05	0.00276	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.39e-05	0.00275	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCR2—ulcerative colitis	5.3e-05	0.0027	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.27e-05	0.00269	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	5.21e-05	0.00266	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCR6—ulcerative colitis	5.09e-05	0.0026	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CALM3—ulcerative colitis	5.08e-05	0.00259	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	5.02e-05	0.00256	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCR6—ulcerative colitis	4.98e-05	0.00254	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	4.96e-05	0.00253	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	4.81e-05	0.00245	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	4.59e-05	0.00234	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—PTGER4—ulcerative colitis	4.48e-05	0.00229	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	4.46e-05	0.00228	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—PTGER4—ulcerative colitis	4.39e-05	0.00224	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—GHRL—ulcerative colitis	4.11e-05	0.00209	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—GHRL—ulcerative colitis	4.02e-05	0.00205	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCR1—ulcerative colitis	3.91e-05	0.00199	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCR1—ulcerative colitis	3.83e-05	0.00195	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.69e-05	0.00188	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—ADCY5—ulcerative colitis	3.68e-05	0.00188	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.63e-05	0.00185	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCR1—ulcerative colitis	3.55e-05	0.00181	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCR1—ulcerative colitis	3.48e-05	0.00177	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.47e-05	0.00177	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.47e-05	0.00177	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCL20—ulcerative colitis	3.44e-05	0.00175	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CHP1—ulcerative colitis	3.4e-05	0.00174	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—ADRB2—ulcerative colitis	3.4e-05	0.00173	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	3.37e-05	0.00172	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCL20—ulcerative colitis	3.36e-05	0.00171	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	3.23e-05	0.00165	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GNA12—ulcerative colitis	3.23e-05	0.00165	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL2—ulcerative colitis	3.22e-05	0.00164	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GNA12—ulcerative colitis	3.16e-05	0.00161	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL20—ulcerative colitis	3.12e-05	0.00159	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCR2—ulcerative colitis	3.06e-05	0.00156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL20—ulcerative colitis	3.05e-05	0.00156	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCR2—ulcerative colitis	3e-05	0.00153	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—DLD—ulcerative colitis	2.94e-05	0.0015	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GNA12—ulcerative colitis	2.93e-05	0.0015	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR6—ulcerative colitis	2.88e-05	0.00147	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GNA12—ulcerative colitis	2.87e-05	0.00146	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR6—ulcerative colitis	2.82e-05	0.00144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCR2—ulcerative colitis	2.78e-05	0.00142	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCR2—ulcerative colitis	2.72e-05	0.00139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR6—ulcerative colitis	2.61e-05	0.00133	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.61e-05	0.00133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR6—ulcerative colitis	2.56e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SEL1L—ulcerative colitis	2.55e-05	0.0013	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PTGER4—ulcerative colitis	2.53e-05	0.00129	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.51e-05	0.00128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SEL1L—ulcerative colitis	2.49e-05	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PTGER4—ulcerative colitis	2.48e-05	0.00126	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.35e-05	0.0012	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	2.32e-05	0.00118	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	2.3e-05	0.00117	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	2.27e-05	0.00116	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	2.25e-05	0.00115	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.16e-05	0.0011	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.16e-05	0.0011	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.12e-05	0.00108	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.11e-05	0.00108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	2.11e-05	0.00107	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	2.1e-05	0.00107	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	2.06e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	2.05e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	2.04e-05	0.00104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	2e-05	0.00102	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CHP1—ulcerative colitis	1.99e-05	0.00102	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.98e-05	0.00101	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.92e-05	0.000979	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.88e-05	0.000958	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	1.84e-05	0.00094	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	1.8e-05	0.000919	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	1.74e-05	0.000889	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	1.73e-05	0.000883	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—DLD—ulcerative colitis	1.72e-05	0.000878	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.72e-05	0.000875	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	1.69e-05	0.000864	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	1.64e-05	0.000837	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	1.64e-05	0.000837	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.63e-05	0.000831	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—DLD—ulcerative colitis	1.62e-05	0.000827	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	1.61e-05	0.000819	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	1.61e-05	0.000819	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.59e-05	0.000813	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	1.54e-05	0.000787	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	1.51e-05	0.00077	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.49e-05	0.000759	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	1.48e-05	0.000755	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	1.46e-05	0.000746	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	1.45e-05	0.000738	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	1.43e-05	0.00073	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS1—ulcerative colitis	1.42e-05	0.000724	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	1.36e-05	0.000693	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	1.33e-05	0.000678	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.33e-05	0.000677	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CALM3—ulcerative colitis	1.28e-05	0.000652	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	1.24e-05	0.000635	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.24e-05	0.000632	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	1.22e-05	0.000621	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	1.21e-05	0.000615	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	1.19e-05	0.000605	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	1.18e-05	0.000601	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	1.16e-05	0.000592	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.16e-05	0.000592	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.16e-05	0.00059	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	1.03e-05	0.000525	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.02e-05	0.000521	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	1.02e-05	0.000518	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—ulcerative colitis	9.94e-06	0.000507	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	9.94e-06	0.000507	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ADCY5—ulcerative colitis	9.28e-06	0.000473	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	9.28e-06	0.000473	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	9.23e-06	0.000471	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	9.07e-06	0.000463	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	9.03e-06	0.00046	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	8.87e-06	0.000452	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	8.75e-06	0.000446	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	8.67e-06	0.000442	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	8.56e-06	0.000436	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	8.42e-06	0.000429	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS1—ulcerative colitis	8.32e-06	0.000424	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	8.24e-06	0.00042	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	8.05e-06	0.00041	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	7.88e-06	0.000402	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS1—ulcerative colitis	7.84e-06	0.0004	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.79e-06	0.000397	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CALM3—ulcerative colitis	7.5e-06	0.000382	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CALM3—ulcerative colitis	7.06e-06	0.00036	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARG—ulcerative colitis	6.92e-06	0.000353	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—ulcerative colitis	6.22e-06	0.000317	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—ulcerative colitis	5.49e-06	0.00028	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	5.45e-06	0.000278	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—ulcerative colitis	5.44e-06	0.000277	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADCY5—ulcerative colitis	5.44e-06	0.000277	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	5.33e-06	0.000272	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	5.28e-06	0.000269	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	5.17e-06	0.000263	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADCY5—ulcerative colitis	5.12e-06	0.000261	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	4.98e-06	0.000254	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	4.87e-06	0.000248	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	4.76e-06	0.000242	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	4.73e-06	0.000241	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	4.65e-06	0.000237	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	4.63e-06	0.000236	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	4.5e-06	0.000229	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	4.45e-06	0.000227	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	4.4e-06	0.000224	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	4.36e-06	0.000222	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARG—ulcerative colitis	4.06e-06	0.000207	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	4e-06	0.000204	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	3.91e-06	0.0002	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.82e-06	0.000195	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	3.71e-06	0.000189	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—ulcerative colitis	3.65e-06	0.000186	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	3.63e-06	0.000185	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—ulcerative colitis	3.44e-06	0.000175	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.19e-06	0.000163	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	3.05e-06	0.000156	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—ulcerative colitis	3.01e-06	0.000153	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	2.99e-06	0.000152	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	2.8e-06	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	2.73e-06	0.000139	CbGpPWpGaD
